retatrutide causing diarrhea More data on dropped today at the ADA conference!! Reta is an investigational -not FDA approved yet- once-weekly medication that simultaneously activates the GIP, GLP-1, and glucagon receptors In the Phase Retatrutide Diarrhea: Rates, Causes &

Consider reducing from 12mg to 8mg for 4 weeks, then 8mg to 4mg for 4 weeks before stopping

At 48 weeks, mean percentage changes in body weight from baseline were approximately: In the 12 mg arm, roughly 100% of participants achieved at least 5% body-weight loss, about 83% reached 15% loss, around 63% achieved 20% loss, and approximately 26% crossed the 25% threshold

Self-inject TRT plans start at $155 per month for eligible self-pay patients and include personalized treatment, ongoing provider oversight, and routine monitoring to help you achieve the best possible results

Weight loss results compared head to head Numbers matter in this comparison